GH axis
Ipamorelin
Selective GHS-R1a agonist · GH axis research
A pentapeptide growth hormone secretagogue receptor agonist developed as a research tool for selective GH release without significant cortisol or prolactin elevation in published preclinical models.
For laboratory research use only. Not for human or animal consumption, not a drug, food, cosmetic, or supplement. By adding to cart, the researcher affirms compliance with all applicable regulations.
Vial size
Research price
$39
SKU VRL-IPA-5
Ships cold-chain · Lot VRL-IPA-2601 · Checkout secured by Waave
Specifications
Ipamorelin is a pentapeptide ghrelin mimetic first characterized by Raun and colleagues at Novo Nordisk. Published research has described its action at the growth hormone secretagogue receptor (GHS-R1a) with notable selectivity for GH release over ACTH, cortisol, and prolactin in preclinical and early clinical studies.
In research contexts, Ipamorelin is frequently paired with a GHRH analog such as CJC-1295 to study the combined effect of two distinct pathways of pulsatile GH release.
Velour provides this material only as a research reference material for GH-axis pathway studies and makes no claim regarding therapeutic, diagnostic, cosmetic, or human/veterinary use.
Related research tools
